LifeWealth Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$921K Buy
768
+9
+1% +$9.2K 0.25% 60
2026
Q1
$698K Buy
759
+39
+5% +$39.5K 0.21% 68
2025
Q4
$774K Buy
720
+20
+3% +$19.1K 0.25% 66
2025
Q3
$534K Buy
700
+18
+3% +$13.4K 0.18% 87
2025
Q2
$532K Buy
682
+110
+19% +$85.5K 0.19% 84
2025
Q1
$472K Buy
572
+113
+25% +$94K 0.23% 83
2024
Q4
$354K Buy
+459
New +$380K 0.23% 94

Other funds holding LLY

LifeWealth Investments's LLY Position: Q2 2026 in Review

LifeWealth Investments increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $9.2K and bringing the position to 768 shares worth $921K. The position accounts for 0.25% of the portfolio, ranked #60.

LifeWealth Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LifeWealth Investments held 768 shares of Eli Lilly worth $921K as of Q2 2026.
  • LifeWealth Investments bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.25% of LifeWealth Investments's portfolio in Q2 2026, its #60 holding.
  • LifeWealth Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LifeWealth Investments's 13F filing for Q2 2026, filed 16 Jul 2026.